<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40999397</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6823</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC endocrine disorders</Title><ISOAbbreviation>BMC Endocr Disord</ISOAbbreviation></Journal><ArticleTitle>Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>210</StartPage><MedlinePgn>210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12902-025-02016-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Carnosine and beta-alanine (&#x3b2;-alanine) have shown potential in the management of chronic conditions, including metabolic disorders. However, their therapeutic efficacy in individuals with type 2 diabetes mellitus (T2DM) and prediabetes remains inconclusive due to heterogeneity in clinical trial results and limited synthesis of human evidence.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This systematic review and meta-analysis aim to evaluate the effects of carnosine and &#x3b2;-alanine supplementation on patients with prediabetes and T2DM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Cochrane Library, Web of Science, and Embase from inception to 9 October 2024 for randomized controlled trials that compared carnosine or &#x3b2;-alanine supplementation to placebo in prediabetic and diabetic populations. The quality of evidence was appraised using the Jadad scale, and the risk of bias was assessed using the Cochrane Risk of Bias tool. Data were analyzed using RevMan and Stata, employing fixed-effects models and I-V methods.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight trials met the inclusion criteria, totaling 377 participants. Our analysis indicated that supplementation significantly reduced fasting blood glucose (FBG) (SMD: -0.53; 95% CI: -0.75 to -0.31; p&#x2009;&lt;&#x2009;0.00001) and hemoglobin A1c (HbA1c) levels (SMD:-0.36; 95% CI:-0.59 to -0.12; p&#x2009;=&#x2009;0.003) compared to placebo. No significant effects were observed on body mass index (BMI), fasting insulin. low-density lipoprotein cholesterol (LDL-c) or high-density lipoprotein cholesterol (HDL-c), but a lowering effect was observed in total cholesterol (TC). Notably, Homeostasis Model Assessment of Beta-cell Function (HOMA-&#x3b2;) values were improved, suggesting enhanced &#x3b2;-cell function, while changes in homeostasis model assessment of insulin resistance (HOMA-IR) did not reach statistical significance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Carnosine and &#x3b2;-alanine supplementation show potential as adjunct therapies for improving FBG, HbA1c and HOMA-&#x3b2; in prediabetes and T2DM. Further rigorous studies are warranted to establish optimal dosage, treatment duration, and long-term efficacy in clinical practice.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yan</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second People's Hospital of Pidu District of Chengdu, Chengdu, 611733, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jingxian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongling</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, 563006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinlei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guangya</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>College of Basic Medicine, Chengdu University, Chengdu, 610081, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Zhonglin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Second People's Hospital of Pidu District of Chengdu, Chengdu, 611733, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xingrong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Second People's Hospital of Pidu District of Chengdu, Chengdu, 611733, Sichuan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China. 15123831283@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, Chengdu University, Chengdu, 610081, Sichuan, P.R. China. 15123831283@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, 610081, Sichuan, P.R. China. shizheng@cdu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, Chengdu University, Chengdu, 610081, Sichuan, P.R. China. shizheng@cdu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.25NSFSC2579, NO.24NSFSC1618, NO.2024YFFK0287</GrantID><Agency>Natural Science Foundation of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.2024LQRD0048</GrantID><Agency>the Key Research and Development Program of Chengdu Economic Development Zone New Economy and Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>NO.CDJGY2024006</GrantID><Agency>Academic Degree and Postgraduate Education Reform Project of Sichuan Province</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>2022291, 2023618</GrantID><Agency>Longquanyi Talent Program, Class C Innovative Talent Program Special Funding; Chengdu Medical Research Project</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>Y202202</GrantID><Agency>Key Projects of Chengdu University School of Clinical Medicine and Affiliated Hospital</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant><Grant><GrantID>2081923030</GrantID><Agency>Chengdu University Research Initiation Programme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Endocr Disord</MedlineTA><NlmUniqueID>101088676</NlmUniqueID><ISSNLinking>1472-6823</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8HO6PVN24W</RegistryNumber><NameOfSubstance UI="D002336">Carnosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>11P2JDE17B</RegistryNumber><NameOfSubstance UI="D015091">beta-Alanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002336" MajorTopicYN="Y">Carnosine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011236" MajorTopicYN="Y">Prediabetic State</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015091" MajorTopicYN="Y">beta-Alanine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carnosine or &#x3b2;-alanine supplementation</Keyword><Keyword MajorTopicYN="N">Prediabetes</Keyword><Keyword MajorTopicYN="N">Randomized controlled trials</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>Author information. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Clinical trial number: Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40999397</ArticleId><ArticleId IdType="doi">10.1186/s12902-025-02016-w</ArticleId><ArticleId IdType="pii">10.1186/s12902-025-02016-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun H, Saeedi P, Karuranga S, et al. Idf diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022. https://doi.org/10.1016/j.diabres.2021.109119 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109119</ArticleId><ArticleId IdType="pubmed">36240956</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. 2020;(2210&#x2013;6014 (Electronic)).&#xa0;J Epidemiol Glob Health. 2020;10:107&#x2013;11. https://doi.org/10.2991/jegh.k.191028.001 .</Citation></Reference><Reference><Citation>Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao ZA-O, Zhao Y. From Pre-Diabetes to diabetes: diagnosis, treatments and translational research. 2020;(1648&#x2013;9144 (Electronic)). Medicina. 2022;55(9). https://doi.org/10.3390/medicina55090546 .</Citation></Reference><Reference><Citation>Global regional, and national burden of diabetes. From 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. 2023;(1474-547X (Electronic)). Lancet. 2023;402(10397):203&#x2013;34. https://doi.org/10.1016/S0140-6736(23)01301-6 .</Citation></Reference><Reference><Citation>Lindahl B, Nilss&#xf6;n TF, Borch-Johnsen K, Borch-Johnsen K, Fau - R&#xf8;der ME et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems. 2009;(1403&#x2013;4948 (Print)).&#xa0;Scand J Public Health. 2009;37(4). https://doi.org/10.1177/1403494808101373 .</Citation></Reference><Reference><Citation>Chandra SA-O, Saklani S, Kumar P, Kim BA-OX, Coutinho HA-O. Nutraceuticals: Pharmacologically Active Potent Dietary Supplements. 2022;(2314&#x2013;6141. BioMed Research International homepage. https://doi.org/10.1155/2022/2051017 .&#xa0;</Citation></Reference><Reference><Citation>Mokgalaboni K, Lebelo SL, Modjadji P, Ghaffary S. Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: a systematic review and meta-analysis of the clinical evidence. Front Pharmacol. 2023;14:1132650. https://doi.org/10.3389/fphar.2023.1132650 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1132650</ArticleId><ArticleId IdType="pubmed">37077817</ArticleId><ArticleId IdType="pmc">10107009</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews JA-O, Dolan E, Swinton PA et al. Effect of carnosine or &#x3b2;-Alanine supplementation on markers of glycemic control and insulin resistance in humans and animals: A systematic review and Meta-analysis. 2021;(2156&#x2013;5376). Advances in Nutrition. 2021;12(6):216&#x2013;31. https://doi.org/10.1093/advances/nmab087 .</Citation></Reference><Reference><Citation>Artioli GG, Sale C, Jones RA-O. Carnosine Health Disease. 2019;(1536&#x2013;7290 (Electronic)). European Journal of Sport Science Process. 2018;19(1). https://doi.org/10.1080/17461391.2018.1444096 .</Citation></Reference><Reference><Citation>Cripps MJ, Hanna K, Lavilla C Jr, et al. Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake. 2017;(2045&#x2013;2322 (Electronic)). Scientific Reports.&#xa0;2017;7:Article number: 13313. https://doi.org/10.1038/s41598-017-13649-w .</Citation></Reference><Reference><Citation>Cesak OA-O, Vostalova JA-O, Vidlar AA-O, Bastlova P, Student VJA-O. Carnosine and Beta-Alanine supplementation in human medicine. Narrative Rev Crit Assess. 2023;(2072&#x2013;6643). Nutrients 2023;15(7):1770. https://doi.org/10.3390/nu15071770 .</Citation></Reference><Reference><Citation>Caruso GA-O, Fresta CG, Fidilio A, et al. Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages. Antioxidants. 2019. https://doi.org/10.3390/antiox8080281 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8080281</ArticleId><ArticleId IdType="pubmed">31817977</ArticleId><ArticleId IdType="pmc">6943631</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews JA-O, Turner MA-O, Santos LA-O, Elliott-Sale KA-O, Sale CA-O. Carnosine increases insulin-stimulated glucose uptake and reduces methylglyoxal-modified proteins in type-2 diabetic human skeletal muscle cells. 2023;(1438&#x2013;2199). Amino Acids. 2023;55:413&#x2013;20. https://doi.org/10.1007/s00726-022-03230-9 .</Citation></Reference><Reference><Citation>Hu Z, Zhang S, Yan X, et al. Pan-cancer analysis of CENPA as a potential prognostic and immunological biomarker in human cancer. Curr Bioinform. 2022;17(7):599&#x2013;614. https://doi.org/10.2174/1574893617666220509205749 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574893617666220509205749</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbarbary NS, Ismail EAR, El-Naggar AR, Hamouda MH, El-Hamamsy M. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial. Pediatr Diabetes. 2018;19:470&#x2013;7. https://doi.org/10.1111/pedi.12564 .</Citation></Reference><Reference><Citation>Liu Y, Cotillard A, Vatier C, et al. A dietary supplement containing cinnamon, chromium and carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS One. 2015. https://doi.org/10.1371/journal.pone.0138646 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138646</ArticleId><ArticleId IdType="pubmed">26720755</ArticleId><ArticleId IdType="pmc">4703137</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MA-O, McKenzie JE, Bossuyt PM, et al.&#xa0;2021 The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (1756&#x2013;1833). BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71 .</Citation></Reference><Reference><Citation>Diagnosis and classification of diabetes mellitus. 2011;(1935&#x2013;5548 (Electronic)). Diabetes Care. 2011;34(Supplement_1). https://doi.org/10.2337/dc11-S062 .</Citation></Reference><Reference><Citation>2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. 2020;(1935&#x2013;5548 (Electronic)). Diabetes Care. 2020;43(Supplement_1):S14&#x2013;31. https://doi.org/10.2337/dc20-S002 .</Citation></Reference><Reference><Citation>Jadad AR, Moore Ra Fau -, Carroll D, Carroll D, Fau - Jenkinson C, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? (0197&#x2013;2456 ). Control Clin Trials. 1996;17(1):1&#x2013;12. https://doi.org/10.1016/0197-2456(95)00134-4 .</Citation></Reference><Reference><Citation>Higgins J, et al. Altman Dg Fau - G&#xf8;tzsche PC, G&#xf8;tzsche Pc Fau - J&#xfc;ni P,. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. 2011;(1756&#x2013;1833 (Electronic)). BMJ. 2011;343. https://doi.org/10.1136/bmj.d5928 .</Citation></Reference><Reference><Citation>Guyatt GH, et al. Oxman Ad Fau - Vist GE, Vist Ge Fau - Kunz R,. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. 2008;(1756&#x2013;1833 (Electronic)). BMJ. 2008;336. https://doi.org/10.1136/bmj.39489.470347 .</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. 2002;(0277&#x2013;6715). Stat Med. https://doi.org/10.1002/sim.1186 .</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Fau - Schneider M, Schneider M, Fau - Minder C, Minder C. Bias in meta-analysis detected by a simple. Graphical Test. 1997;(0959&#x2013;8138). BMJ. 1997;315. https://doi.org/10.1136/bmj.315.7109.629 .</Citation></Reference><Reference><Citation>Hariharan R, Cameron J, Menon K, et al. Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: a randomised controlled trial. Nutr Metab Cardiovasc Dis. 2024;34(2):485&#x2013;96. https://doi.org/10.1016/j.numecd.2023.10.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2023.10.012</ArticleId><ArticleId IdType="pubmed">38172006</ArticleId></ArticleIdList></Reference><Reference><Citation>Houjeghani S, Kheirouri S, Faraji E, Jafarabadi MA. L-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor&#x2013;&#x3b1; levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial. Article. Nutr Res. 2017;49:96&#x2013;106. https://doi.org/10.1016/j.nutres.2017.11.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2017.11.003</ArticleId><ArticleId IdType="pubmed">29420997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rs N, Wr S. The effect of 28 days of Beta-alanine supplementation on exercise capacity and insulin sensitivity in individuals with type 2 diabetes mellitus: A randomised, Double-blind and Placebo-controlled pilot trial. Sports Nutr Therapy. 2016;01(03). https://doi.org/10.4172/2473-6449.1000111 .</Citation></Reference><Reference><Citation>Saadati S, Cameron J, Menon K, et al. Carnosine did not affect vascular and metabolic outcomes in patients with prediabetes and type 2 diabetes: a 14-week randomized controlled trial. Nutrients. 2023. https://doi.org/10.3390/nu15224835 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15224835</ArticleId><ArticleId IdType="pubmed">38004228</ArticleId><ArticleId IdType="pmc">10674211</ArticleId></ArticleIdList></Reference><Reference><Citation>Siriwattanasit N, Satirapoj B, Supasyndh O. Effect of oral carnosine supplementation on urinary TGF-&#x3b2; in diabetic nephropathy: a randomized controlled trial. BMC Nephrol. 2021;22(1): 236. https://doi.org/10.1186/s12882-021-02434-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-021-02434-7</ArticleId><ArticleId IdType="pubmed">34174842</ArticleId><ArticleId IdType="pmc">8235831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamouda MH, Afifi H, Ibrahim NA, Rabea H, Salem HF. Role of carnosine in combination with vitamin B complex in preventing the progression of diabetic neuropathy in people with type 2 diabetes. Clin Diabetes Spring. 2025;43(2):303&#x2013;11. https://doi.org/10.2337/cd24-0092 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/cd24-0092</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldyrev AA, Stvolinsky Sl, Fau, Tyulina OV, Tyulina Ov, Fau, Koshelev VB, Koshelev Vb, Fau, Hori N, Hori N, Fau, Carpenter DO, Carpenter DO. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol.&#xa0;Cell Mol Neurobiol. 1997;17(2):259-71. https://doi.org/10.1023/a:1026374114314 .&#xa0;</Citation></Reference><Reference><Citation>Boldyrev Aa Fau -, Aldini G, Aldini G, Fau - Derave W, Derave W. Physiology and pathophysiology of carnosine. 2013;(1522&#x2009;&#x2013;&#x2009;1210).Physiol Rev. 2013;93(4):1803&#x2013;45. https://doi.org/10.1152/physrev.00039.2012 .</Citation></Reference><Reference><Citation>Calabrese VA-OX, Scuto MA-O, Salinaro AA-OX, et al. Hydrogen sulfide and carnosine: modulation of oxidative stress and inflammation in kidney and brain axis. (2076&#x2013;3921). Antioxidants. 2020;9(12):1303. https://doi.org/10.3390/antiox9121303 .</Citation></Reference><Reference><Citation>Miceli V, Pampalone M, Frazziano G, et al. Carnosine protects pancreatic beta cells and islets against oxidative stress damage. Mol Cell Endocrinol. 2018;474:105&#x2013;18. https://doi.org/10.1016/j.mce.2018.02.016 .</Citation></Reference><Reference><Citation>Feng N, Feng Y, Tan J, et al. Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: a comprehensive review. Int J Biol Macromol. 2023;249:125814. https://doi.org/10.1016/j.ijbiomac.2023.125814 .</Citation></Reference><Reference><Citation>Babizhayev MA, Guiotto A, Fau - Kasus-Jacobi A, Kasus-Jacobi A. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. 2009;(1029&#x2013;2330).&#xa0;J Drug Target. 2009;17(1). https://doi.org/10.1080/10611860802438736 .</Citation></Reference><Reference><Citation>Schnuck JK, Sunderland KL, Kuennen MR, Vaughan RA. Characterization of the metabolic effect of &#x3b2;-alanine on markers of oxidative metabolism and mitochondrial biogenesis in skeletal muscle. J Exerc Nutr Biochem. 2016. https://doi.org/10.20463/jenb.2016.06.20.2.5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.20463/jenb.2016.06.20.2.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokarz VL, MacDonald PA-O, Klip AA-O. Cell Biology Systemic Insulin Function. 2018;(1540&#x2013;8140 (Electronic)).J Cell Biol. 2018;217(7):2273&#x2013;89. https://doi.org/10.1083/jcb.201802095 .</Citation></Reference><Reference><Citation>Tao X, Jiang M, Liu Y, et al. Predicting three-month fasting blood glucose and glycated hemoglobin changes in patients with type 2 diabetes mellitus based on multiple machine learning algorithms. Sci Rep. 2023;13: 16437. https://doi.org/10.1038/s41598-023-43240-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-43240-5</ArticleId><ArticleId IdType="pubmed">37777593</ArticleId><ArticleId IdType="pmc">10543442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CH, Kim HK, Kim EH, Bae SJ, Choe J, Park JY. Longitudinal changes in insulin resistance, beta-cell function and glucose regulation status in prediabetes. Am J Med Sci. 2018;355(1):54&#x2013;60. https://doi.org/10.1016/j.amjms.2017.09.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2017.09.010</ArticleId><ArticleId IdType="pubmed">29289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;ros T, Laine S, Garthwaite T, et al. Reducing sedentary time and whole-body insulin sensitivity in metabolic syndrome: a 6-month randomized controlled trial. Med Sci Sports Exerc. 2023. https://doi.org/10.1249/mss.0000000000003054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/mss.0000000000003054</ArticleId><ArticleId IdType="pubmed">36251378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakka TA, Lintu N, V&#xe4;ist&#xf6; J, et al. A 2 year physical activity and dietary intervention attenuates the increase in insulin resistance in a general population of children: the PANIC study. Diabetologia Nov. 2020;63(11):2270&#x2013;81. https://doi.org/10.1007/s00125-020-05250-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05250-0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>